UBS Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
2020
Q4
$23K Buy
2020
Q3
$1K Sell
2020
Q2
$16K Sell
2020
Q1
$160K Sell
2019
Q4
$668K Buy
2019
Q3
$31K Sell
2019
Q2
$41K Buy
2019
Q1
$4K Sell
2018
Q4
$10K Sell
2018
Q3
$17K Buy
2018
Q2
$32K Buy